The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2026

Filed:

Apr. 24, 2020
Applicant:

Actinium Pharmaceuticals, Inc., New York, NY (US);

Inventor:

Dale L. Ludwig, Rockaway, NJ (US);

Assignee:

ACTINIUM PHARMACEUTICALS, INC., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/10 (2006.01); A61K 35/28 (2015.01); A61K 39/00 (2006.01); A61P 35/02 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 51/1027 (2013.01); A61K 35/28 (2013.01); A61K 51/103 (2013.01); A61P 35/02 (2018.01); C07K 16/2803 (2013.01); C07K 16/2863 (2013.01); C07K 16/2896 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01);
Abstract

This invention provides a method for depleting a subject's hematopoietic stem cells that includes administering to the subject an effective amount of a radiolabeled antibody against CD34, CD117, or CD135, where preferred radiolabels includeI andAc. This invention also provides a method for treating a subject afflicted with a non-cancerous disorder treatable via genetically edited cell therapy, where the method includes (i) administering to the subject an amount of the radiolabeled antibody effective to deplete the subject's hematopoietic stem cells, and (ii) after a suitable time period, performing the therapy on the subject to treat the subject's disorder. Finally, this invention provides articles of manufacture for performing the subject methods.


Find Patent Forward Citations

Loading…